Literature DB >> 15879144

Regulation of c-Jun phosphorylation by the I kappa B kinase-epsilon complex in fibroblast-like synoviocytes.

Susan E Sweeney1, Deepa Hammaker, David L Boyle, Gary S Firestein.   

Abstract

Rheumatoid arthritis (RA) causes a symmetric, inflammatory polyarthritis that results in joint destruction and significant disability. Signaling pathways that regulate the production of cytokines and destructive enzymes have been implicated in its pathogenesis and represent potential therapeutic targets. The IkappaB kinase (IKK)-related kinase, IKKepsilon/IKKi, which plays a pivotal role in regulating antiviral gene transcription, is constitutively expressed by cultured fibroblast-like synoviocytes (FLS) and could participate in the pathogenesis of RA. In the current studies we demonstrate that IKKepsilon protein is expressed in RA and osteoarthritis synovium and that the protein is found primarily in the synovial intimal lining. Functional studies in cultured FLS showed that IKKepsilon kinase activity is rapidly induced by cytokines, although IkappaB phosphorylation is significantly less compared with IKK2. Because NF-kappaB activation is similar in wild-type and IKKepsilon knockout murine FLS, studies were performed to identify an alternative substrate for IKKepsilon. Interestingly, c-Jun is a more efficient substrate for IKKepsilon immunocomplexes in human FLS and this activity appears to be independent of JNK. The functional relevance of IKKepsilon was examined using murine IKKepsilon(-/-) cultured FLS. IL-1-, TNF-alpha-, and LPS-mediated induction of matrix metalloproteinases, MMP3 and MMP13, is significantly decreased in the IKKepsilon(-/-) cells. These data suggest a novel role for the IKKepsilon complex in synovial inflammation, extracellular matrix destruction, and activation of the viral program and innate immune response in RA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879144     DOI: 10.4049/jimmunol.174.10.6424

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Role of interferon regulatory factor 7 in serum-transfer arthritis: regulation of interferon-β production.

Authors:  Susan E Sweeney; Maripat Corr; Trevor B Kimbler
Journal:  Arthritis Rheum       Date:  2011-11-10

2.  Synoviocyte innate immune responses: II. Pivotal role of IFN regulatory factor 3.

Authors:  Susan E Sweeney; Trevor B Kimbler; Gary S Firestein
Journal:  J Immunol       Date:  2010-05-17       Impact factor: 5.422

3.  JAB1 determines the response of rheumatoid arthritis synovial fibroblasts to tumor necrosis factor-alpha.

Authors:  Jianhua Wang; Chuanyu Li; Yuelong Liu; Wan Mei; Shaohua Yu; Cunren Liu; Liming Zhang; Xu Cao; Robert P Kimberly; William Grizzle; Huang-Ge Zhang
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

Review 4.  Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors.

Authors:  Nunzio Bottini; Gary S Firestein
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

5.  Targeting interferon regulatory factors to inhibit activation of the type I IFN response: implications for treatment of autoimmune disorders.

Authors:  Susan E Sweeney
Journal:  Cell Immunol       Date:  2011-08-10       Impact factor: 4.868

Review 6.  Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.

Authors:  Beatrix Bartok; Gary S Firestein
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

7.  Use of supplementary phenotype to identify additional rheumatoid arthritis loci in a linkage analysis of 342 UK affected sibling pair families.

Authors:  Bamidele O Tayo; Yulan Liang; Arpad Kelemen; Austin Miller; Maurizio Trevisan; Richard S Cooper
Journal:  BMC Med Genet       Date:  2009-12-21       Impact factor: 2.103

8.  Specification of the NF-kappaB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon.

Authors:  Rita Moreno; Jürgen-Markus Sobotzik; Christian Schultz; M Lienhard Schmitz
Journal:  Nucleic Acids Res       Date:  2010-05-27       Impact factor: 16.971

Review 9.  Advances in targeting IKK and IKK-related kinases for cancer therapy.

Authors:  Dung-Fang Lee; Mien-Chie Hung
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

10.  Autocrine motility factor stimulates the invasiveness of malignant cells as well as up-regulation of matrix metalloproteinase-3 expression via a MAPK pathway.

Authors:  Arayo Haga; Tatsuyoshi Funasaka; Yoshihiro Deyashiki; Avraham Raz
Journal:  FEBS Lett       Date:  2008-05-15       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.